Cornerstone Capital Management Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.35M	Sell	24,294 -1,600	-6%	-$84.8K	0.01%	844
2017 Q3	$1.17M	Buy	25,894 +300	+1%	+$12K	0.01%	895
2017 Q2	$862K	Sell	25,594 -109	-0.4%	-$3.55K	0.01%	938
2017 Q1	$760K	Buy	25,703 +20,003	+351%	+$619K	0.01%	979
2016 Q4	$155K	Buy	5,700 +3,400	+148%	+$137K	﹤0.01%	1216
2016 Q3	$140K	Buy	+2,300	New	+$69.5K	﹤0.01%	1230
2016 Q1	–	Sell	-3,654	Closed	-$141K	–	1547
2015 Q4	$141K	Buy	3,654 +1,154	+46%	+$37.4K	﹤0.01%	1269
2015 Q3	$80K	Buy	2,500 +1,300	+108%	+$44.1K	﹤0.01%	1355
2015 Q2	$37K	Buy	+1,200	New	+$24.5K	﹤0.01%	1373

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cornerstone Capital Management Holdings's SRPT Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Sarepta Therapeutics (SRPT) stake by 6.2% in Q4 2017, selling an estimated $84.8K and leaving 24,294 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #844.

Cornerstone Capital Management Holdings first reported a position in SRPT in Q2 2015 and has held it in 9 quarters since. 254 funds tracked by Wall St. Rank hold SRPT as of Q4 2017.

Cornerstone Capital Management Holdings held 24,294 shares of Sarepta Therapeutics worth $1.35M as of Q4 2017.
Cornerstone Capital Management Holdings sold 1,600 Sarepta Therapeutics shares in Q4 2017, an estimated $84.8K.
Sarepta Therapeutics made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #844 holding.
Cornerstone Capital Management Holdings first reported a position in Sarepta Therapeutics in Q2 2015 and has held it in 9 quarters since.
254 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.